Menu
Home
People
Places
Arts
History
Plants & Animals
Science
Life & Culture
Technology
Reference.org
GABRA2
open-in-new
<h2 id="structure">Structure</h2> <p>GABRA2 is one of the 16 distinct alpha subunits found for the GABA receptor. GABA-A has a pentametric form, with two alpha, two beta, and one gamma subunit.<a class="footnote-ref" id="fnref:5" href="#fn:5"><sup>5</sup></a> The various subunit isoforms seen in the GABA-A receptor structure have an effect on its function. GABRA2 is most often seen as part of the most common expression α2β3γ2, which is seen in 13% of all GABA-A receptors.<a class="footnote-ref" id="fnref:6" href="#fn:6"><sup>6</sup></a> The subunit, GABRA2, is found primarily in the <a href="/facts/Hippocampus/X7CqbP8X">hippocampus</a> and/or the <a href="/facts/Forebrain/X3H1IqLq">forebrain</a>. It is more confined to areas of the brain in comparison to other alpha subunits seen in GABA-A receptors. It is present in 35% of all GABA-A receptors being the fourth most abundant subunit next to <a href="/facts/Gamma-aminobutyric_acid_receptor_subunit_alpha-1/sJ4oePxY">GABRA1</a> and various beta subunits. Like all subunits, it is made from structurally distinct proteins. The presence of this subunit causes an easier binding of benzodiazepine which is a category of <a href="/facts/Psychoactive_drug/dNXrUmsx">psychoactive drugs</a>.<a class="footnote-ref" id="fnref:7" href="#fn:7"><sup>7</sup></a> </p><h2 id="function">Function</h2> <p>GABRA2 mediates neural activity necessary for information processing in inter-neurons.<a class="footnote-ref" id="fnref:8" href="#fn:8"><sup>8</sup></a> GABRA2 participates in transporting Cl− ions into the membrane, since it forms part of the <a href="/facts/GABAA_receptor/6G4rAGb3">GABA-A receptor</a>. The influx of Cl− causes the hyper-polarization of the membrane, leading to inhibitory actions. </p><p>GABRA2 increases the risk of anxiety making it a target for treating <a href="/facts/Emotional_and_behavioral_disorders/p7u5jGGr">behavioral disorders</a>.<a class="footnote-ref" id="fnref:9" href="#fn:9"><sup>9</sup></a> Some examples of behavioral disorders include anxiety, alcohol dependence, and drug use. GABRA2 is a binding site for benzodiazepines. Benzodiazepines are psychoactive drugs known to reduce anxiety. Benzodiazepines bind to GABRA2 causing chloride channels to open, leading to the hyper-polarization of the membrane.<a class="footnote-ref" id="fnref:10" href="#fn:10"><sup>10</sup></a> Other anxiolytic drugs like <a href="/facts/Diazepam/h7lIGqkM">Diazepam</a> target this alpha subunit in GABA-A to induce inhibitory effects.<a class="footnote-ref" id="fnref:11" href="#fn:11"><sup>11</sup></a> </p><p>GABRA2 is associated with reward behavior when it activates the <a href="/facts/Insular_cortex/lbDKs2e8">insula</a>.<a class="footnote-ref" id="fnref:12" href="#fn:12"><sup>12</sup></a> The insula is part of the cerebral cortex responsible for emotions. GABRA2 role in reward behavior explains the higher risk of alcohol dependence and drug use behavior. </p> <h2 id="clinical-significance">Clinical significance</h2> <p>Since GABRA 2 mediates anxiolytic activity, it is a key receptor for emotional control. Several developmental stages of GABRA2 have shown effects on behavior such as adult alcohol dependence and adolescent behavior. </p> <h3>Alcoholism</h3> <p>Since GABRA 2 subunit mediates anxiolytic activity, long term use or withdrawal of ethanol can cause dependence alterations in the GABA-A receptor.<a class="footnote-ref" id="fnref:13" href="#fn:13"><sup>13</sup></a> </p><p>When alcohol is present in the brain, it affects two types of receptors: GABA-A, inhibitory receptors, and <a href="/facts/Glutamate_(neurotransmitter)/GRqBSJ1P">Glutamate</a>, excitatory receptors. In GABA receptors, alcohol substrates bind allosterically, which allows the GABA receptors to increase their inhibitory activity. Besides giving GABA receptors an extra inhibitory punch, alcohol substrates bind to glutamate receptors, which blocks its excitatory activity. Alcohol effects on both of these metabolic pathways obstruct the brain from making memories, making well thought out decisions, and controlling impulses after long term use.<a class="footnote-ref" id="fnref:14" href="#fn:14"><sup>14</sup></a> </p><p>Collaborative Study on Genetics of Alcoholism (COGA) identified alcohol dependence on chromosome 4p, where <a href="/facts/SNP_genotyping/3NXuFjLU">SNP</a> genotyping, and measurement of genetic variation, found GABRA2's association with alcoholism within European and African ancestries. Most of these findings were strongly associated with early alcohol use and along with drug dependence. Besides these findings, COGA investigators identified GABRA2 associated with impulsiveness and found other phenotypes affected by alcohol such as <a href="/facts/Beta_wave/lcqYonEV">EEG</a>-β.<a class="footnote-ref" id="fnref:15" href="#fn:15"><sup>15</sup></a> </p> <h3>Adolescent behavior</h3> <p>The International Behavioural and Neural Genetics Society reviewed studies that found a linkage between β1-subunits in GABA-A receptors and excitability in the reward sensitivity behavior brain region. The linkage between these two suggests that inadequate GABRA2 variants can cause the development of mental disorders, such as addiction. The addictive behaviors can be seen as aggressive and defiant, but most of these behaviors can be caused by both genetic and environmental factors.<a class="footnote-ref" id="fnref:16" href="#fn:16"><sup>16</sup></a> </p><p>GABRA2 genes have been linked to various behavioral traits, such as an absence of impulse control. At least 11 single nucleotide polymorphisms, or SNPs, within the GARBRA2 gene have been correlated to impulsivity and four of which were also found in alcoholism. There was an elevated neuronal activation in the insula and the <a href="/facts/Nucleus_accumbens/2M43u5X4">Nucleus accumbens</a>.<a class="footnote-ref" id="fnref:17" href="#fn:17"><sup>17</sup></a> In animals, such as rats, a relationship was found between elevated alcohol consumption and increased impulsivity to those exposed to stress at an early stage in life. This impulsivity can be reversed with pharmacological handling of GABA-A receptors containing GABRA2 in certain neurological areas.<a class="footnote-ref" id="fnref:18" href="#fn:18"><sup>18</sup></a> </p> <h2 id="ligands">Ligands</h2> <h3>Positive allosteric modulators</h3> <p>Selective positive allosteric modulators of the α2-containing GABA-A receptor produce anxioselective effects.<a class="footnote-ref" id="fnref:19" href="#fn:19"><sup>19</sup></a> </p> <ul><li><a href="/facts/Alpidem/EuMb4tm3">Alpidem</a></li> <li><a href="/facts/Clobazam/KPoBQzyw">Clobazam</a></li> <li><a href="/facts/TPA-023/uFJYqTch">TPA-023</a></li> <li><a href="/facts/L-838%2c417/Ulm5QXbf">L-838,417</a></li></ul> <h2 id="see-also">See also</h2> <ul><li><a href="/facts/GABAA_receptor/6G4rAGb3">GABAA receptor</a></li></ul> <h2 id="further-reading">Further reading</h2> <ul><li>Engin E, Liu J, Rudolph U (November 2012). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478960">"α2-containing GABA(A) receptors: a target for the development of novel treatment strategies for CNS disorders"</a>. <i>Pharmacology & Therapeutics</i>. 136 (2): 142–152. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1016%2Fj.pharmthera.2012.08.006">10.1016/j.pharmthera.2012.08.006</a>. <a href="/facts/PMC_(identifier)/dX1zMt71">PMC</a> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478960">3478960</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/22921455">22921455</a>.</li> <li>Matthews AG, Hoffman EK, Zezza N, Stiffler S, Hill SY (September 2007). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285563">"The role of the GABRA2 polymorphism in multiplex alcohol dependence families with minimal comorbidity: within-family association and linkage analyses"</a>. <i>Journal of Studies on Alcohol and Drugs</i>. 68 (5): 625–633. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.15288%2Fjsad.2007.68.625">10.15288/jsad.2007.68.625</a>. <a href="/facts/PMC_(identifier)/dX1zMt71">PMC</a> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285563">3285563</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/17690794">17690794</a>.</li> <li>Drgon T, D'Addario C, Uhl GR (December 2006). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922197">"Linkage disequilibrium, haplotype and association studies of a chromosome 4 GABA receptor gene cluster: candidate gene variants for addictions"</a>. <i>American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics</i>. 141B (8): 854–860. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1002%2Fajmg.b.30349">10.1002/ajmg.b.30349</a>. <a href="/facts/PMC_(identifier)/dX1zMt71">PMC</a> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922197">3922197</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/16894595">16894595</a>.</li> <li>Agrawal A, Edenberg HJ, Foroud T, Bierut LJ, Dunne G, Hinrichs AL, Nurnberger JI, Crowe R, Kuperman S, Schuckit MA, Begleiter H, Porjesz B, Dick DM (September 2006). "Association of GABRA2 with drug dependence in the collaborative study of the genetics of alcoholism sample". <i>Behavior Genetics</i>. 36 (5): 640–650. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1007%2Fs10519-006-9069-4">10.1007/s10519-006-9069-4</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/16622805">16622805</a>. <a href="/facts/S2CID_(identifier)/ldJsHa2Y">S2CID</a> <a href="https://api.semanticscholar.org/CorpusID:7491312">7491312</a>.</li> <li>Dick DM, Bierut L, Hinrichs A, Fox L, Bucholz KK, Kramer J, Kuperman S, Hesselbrock V, Schuckit M, Almasy L, Tischfield J, Porjesz B, Begleiter H, Nurnberger J, Xuei X, Edenberg HJ, Foroud T (July 2006). "The role of GABRA2 in risk for conduct disorder and alcohol and drug dependence across developmental stages". <i>Behavior Genetics</i>. 36 (4): 577–590. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1007%2Fs10519-005-9041-8">10.1007/s10519-005-9041-8</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/16557364">16557364</a>. <a href="/facts/S2CID_(identifier)/ldJsHa2Y">S2CID</a> <a href="https://api.semanticscholar.org/CorpusID:15513277">15513277</a>.</li> <li>Tian H, Chen HJ, Cross TH, Edenberg HJ (June 2005). "Alternative splicing and promoter use in the human GABRA2 gene". <i>Brain Research. Molecular Brain Research</i>. 137 (1–2): 174–183. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1016%2Fj.molbrainres.2005.03.001">10.1016/j.molbrainres.2005.03.001</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/15950776">15950776</a>.</li> <li>Chou KC (April 2004). "Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5". <i>Biochemical and Biophysical Research Communications</i>. 316 (3): 636–642. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1016%2Fj.bbrc.2004.02.098">10.1016/j.bbrc.2004.02.098</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/15033447">15033447</a>.</li> <li>Edenberg HJ, Dick DM, Xuei X, Tian H, Almasy L, Bauer LO, Crowe RR, Goate A, Hesselbrock V, Jones K, Kwon J, Li TK, Nurnberger JI, O'Connor SJ, Reich T, Rice J, Schuckit MA, Porjesz B, Foroud T, Begleiter H (April 2004). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1181946">"Variations in GABRA2, encoding the alpha 2 subunit of the GABA(A) receptor, are associated with alcohol dependence and with brain oscillations"</a>. <i>American Journal of Human Genetics</i>. 74 (4): 705–714. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1086%2F383283">10.1086/383283</a>. <a href="/facts/PMC_(identifier)/dX1zMt71">PMC</a> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1181946">1181946</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/15024690">15024690</a>.</li> <li>Bonnert TP, McKernan RM, Farrar S, le Bourdellès B, Heavens RP, Smith DW, Hewson L, Rigby MR, Sirinathsinghji DJ, Brown N, Wafford KA, Whiting PJ (August 1999). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC22306">"theta, a novel gamma-aminobutyric acid type A receptor subunit"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. 96 (17): 9891–9896. <a href="/facts/Bibcode_(identifier)/9HtdQSGB">Bibcode</a>:<a href="https://ui.adsabs.harvard.edu/abs/1999PNAS...96.9891B">1999PNAS...96.9891B</a>. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1073%2Fpnas.96.17.9891">10.1073/pnas.96.17.9891</a>. <a href="/facts/PMC_(identifier)/dX1zMt71">PMC</a> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC22306">22306</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/10449790">10449790</a>.</li> <li>Russek SJ (February 1999). "Evolution of GABA(A) receptor diversity in the human genome". <i>Gene</i>. 227 (2): 213–222. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1016%2FS0378-1119%2898%2900594-0">10.1016/S0378-1119(98)00594-0</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/10023064">10023064</a>.</li> <li>Hadingham KL, Wingrove P, Le Bourdelles B, Palmer KJ, Ragan CI, Whiting PJ (June 1993). "Cloning of cDNA sequences encoding human alpha 2 and alpha 3 gamma-aminobutyric acidA receptor subunits and characterization of the benzodiazepine pharmacology of recombinant alpha 1-, alpha 2-, alpha 3-, and alpha 5-containing human gamma-aminobutyric acidA receptors". <i>Molecular Pharmacology</i>. 43 (6): 970–975. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1016%2FS0026-895X%2825%2913682-1">10.1016/S0026-895X(25)13682-1</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/8391122">8391122</a>.</li> <li>Tögel M, Mossier B, Fuchs K, Sieghart W (April 1994). <a href="https://doi.org/10.1016%2FS0021-9258%2818%2999974-6">"gamma-Aminobutyric acidA receptors displaying association of gamma 3-subunits with beta 2/3 and different alpha-subunits exhibit unique pharmacological properties"</a>. <i>The Journal of Biological Chemistry</i>. 269 (17): 12993–12998. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1016%2FS0021-9258%2818%2999974-6">10.1016/S0021-9258(18)99974-6</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/8175718">8175718</a>.</li></ul> <h2 id="external-links">External links</h2> <ul><li><a href="https://meshb.nlm.nih.gov/record/ui?name=GABRA2+protein%2C+human">GABRA2+protein,+human</a> at the U.S. National Library of Medicine <a href="/facts/Medical_Subject_Headings/C57g2JuF">Medical Subject Headings</a> (MeSH)</li></ul> <p><i>This article incorporates text from the <a href="/facts/United_States_National_Library_of_Medicine/Hzty0MCX">United States National Library of Medicine</a>, which is in the <a href="/facts/Public_domain/YWKMDKw4">public domain</a>.</i> </p> <h2 id="references">References</h2> <ol> <li id="fn:1"><p>"GABRA2 gamma-aminobutyric acid type A receptor alpha2 subunit [Homo sapiens (human)]". Gene - NCBI. <a href="https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=ShowDetailView&TermToSearch=2555" target="_blank">https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=ShowDetailView&TermToSearch=2555</a> <a href="#fnref:1" class="footnote-back-ref">↩</a></p></li> <li id="fn:2"><p>"Entrez Gene: GABRA2 gamma-aminobutyric acid (GABA) A receptor, alpha 2". <a href="https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2555" target="_blank">https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2555</a> <a href="#fnref:2" class="footnote-back-ref">↩</a></p></li> <li id="fn:3"><p>Hanns S, Möhler H (2007). The GABA Receptor. New York: Humana Press. pp. 23–31, 69–87, 87–111. ISBN 978-1-59745-465-0. <a href="978-1-59745-465-0" target="_blank">978-1-59745-465-0</a> <a href="#fnref:3" class="footnote-back-ref">↩</a></p></li> <li id="fn:4"><p>Enoch MA (July 2008). "The role of GABA(A) receptors in the development of alcoholism". Pharmacology Biochemistry and Behavior. New Insights Into the Function of GABAA Receptor Subtypes. 90 (1): 95–104. doi:10.1016/j.pbb.2008.03.007. PMC 2577853. PMID 18440057. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577853" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577853</a> <a href="#fnref:4" class="footnote-back-ref">↩</a></p></li> <li id="fn:5"><p>Hanns S, Möhler H (2007). The GABA Receptor. New York: Humana Press. pp. 23–31, 69–87, 87–111. ISBN 978-1-59745-465-0. <a href="978-1-59745-465-0" target="_blank">978-1-59745-465-0</a> <a href="#fnref:5" class="footnote-back-ref">↩</a></p></li> <li id="fn:6"><p>Enoch MA (July 2008). "The role of GABA(A) receptors in the development of alcoholism". Pharmacology Biochemistry and Behavior. New Insights Into the Function of GABAA Receptor Subtypes. 90 (1): 95–104. doi:10.1016/j.pbb.2008.03.007. PMC 2577853. PMID 18440057. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577853" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577853</a> <a href="#fnref:6" class="footnote-back-ref">↩</a></p></li> <li id="fn:7"><p>Hanns S, Möhler H (2007). The GABA Receptor. New York: Humana Press. pp. 23–31, 69–87, 87–111. ISBN 978-1-59745-465-0. <a href="978-1-59745-465-0" target="_blank">978-1-59745-465-0</a> <a href="#fnref:7" class="footnote-back-ref">↩</a></p></li> <li id="fn:8"><p>Hanns S, Möhler H (2007). The GABA Receptor. New York: Humana Press. pp. 23–31, 69–87, 87–111. ISBN 978-1-59745-465-0. <a href="978-1-59745-465-0" target="_blank">978-1-59745-465-0</a> <a href="#fnref:8" class="footnote-back-ref">↩</a></p></li> <li id="fn:9"><p>Engin E, Liu J, Rudolph U (November 2012). "α2-containing GABA(A) receptors: a target for the development of novel treatment strategies for CNS disorders". Pharmacology & Therapeutics. 136 (2): 142–152. doi:10.1016/j.pharmthera.2012.08.006. PMC 3478960. PMID 22921455. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478960" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478960</a> <a href="#fnref:9" class="footnote-back-ref">↩</a></p></li> <li id="fn:10"><p>Nuss P (2015-01-17). "Anxiety disorders and GABA neurotransmission: a disturbance of modulation". Neuropsychiatric Disease and Treatment. 11: 165–175. doi:10.2147/NDT.S58841. PMC 4303399. PMID 25653526. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303399" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303399</a> <a href="#fnref:10" class="footnote-back-ref">↩</a></p></li> <li id="fn:11"><p>Hanns S, Möhler H (2007). The GABA Receptor. New York: Humana Press. pp. 23–31, 69–87, 87–111. ISBN 978-1-59745-465-0. <a href="978-1-59745-465-0" target="_blank">978-1-59745-465-0</a> <a href="#fnref:11" class="footnote-back-ref">↩</a></p></li> <li id="fn:12"><p>Engin E, Liu J, Rudolph U (November 2012). "α2-containing GABA(A) receptors: a target for the development of novel treatment strategies for CNS disorders". Pharmacology & Therapeutics. 136 (2): 142–152. doi:10.1016/j.pharmthera.2012.08.006. PMC 3478960. PMID 22921455. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478960" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478960</a> <a href="#fnref:12" class="footnote-back-ref">↩</a></p></li> <li id="fn:13"><p>Hanns S, Möhler H (2007). The GABA Receptor. New York: Humana Press. pp. 23–31, 69–87, 87–111. ISBN 978-1-59745-465-0. <a href="978-1-59745-465-0" target="_blank">978-1-59745-465-0</a> <a href="#fnref:13" class="footnote-back-ref">↩</a></p></li> <li id="fn:14"><p>Sullivan EV, Harris RA, Pfefferbaum A (2010). "Alcohol's effects on brain and behavior". Alcohol Research & Health. 33 (1–2): 127–143. PMC 3625995. PMID 23579943. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625995" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625995</a> <a href="#fnref:14" class="footnote-back-ref">↩</a></p></li> <li id="fn:15"><p>Edenberg HJ, Foroud T (August 2013). "Genetics and alcoholism". Nature Reviews. Gastroenterology & Hepatology. 10 (8): 487–494. doi:10.1038/nrgastro.2013.86. PMC 4056340. PMID 23712313. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056340" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056340</a> <a href="#fnref:15" class="footnote-back-ref">↩</a></p></li> <li id="fn:16"><p>Stephens DN, King SL, Lambert JJ, Belelli D, Duka T (January 2017). "GABAA receptor subtype involvement in addictive behaviour". Genes, Brain and Behavior. 16 (1): 149–184. doi:10.1111/gbb.12321. PMID 27539865. <a href="https://doi.org/10.1111%2Fgbb.12321" target="_blank">https://doi.org/10.1111%2Fgbb.12321</a> <a href="#fnref:16" class="footnote-back-ref">↩</a></p></li> <li id="fn:17"><p>Stephens DN, King SL, Lambert JJ, Belelli D, Duka T (January 2017). "GABAA receptor subtype involvement in addictive behaviour". Genes, Brain and Behavior. 16 (1): 149–184. doi:10.1111/gbb.12321. PMID 27539865. <a href="https://doi.org/10.1111%2Fgbb.12321" target="_blank">https://doi.org/10.1111%2Fgbb.12321</a> <a href="#fnref:17" class="footnote-back-ref">↩</a></p></li> <li id="fn:18"><p>Stephens DN, King SL, Lambert JJ, Belelli D, Duka T (January 2017). "GABAA receptor subtype involvement in addictive behaviour". Genes, Brain and Behavior. 16 (1): 149–184. doi:10.1111/gbb.12321. PMID 27539865. <a href="https://doi.org/10.1111%2Fgbb.12321" target="_blank">https://doi.org/10.1111%2Fgbb.12321</a> <a href="#fnref:18" class="footnote-back-ref">↩</a></p></li> <li id="fn:19"><p>Atack JR (2011). "GABAA receptor subtype-selective modulators. I. α2/α3-selective agonists as non-sedating anxiolytics". Current Topics in Medicinal Chemistry. 11 (9): 1176–1202. doi:10.2174/156802611795371350. ISSN 1873-4294. PMID 21050172. <a href="https://pubmed.ncbi.nlm.nih.gov/21050172" target="_blank">https://pubmed.ncbi.nlm.nih.gov/21050172</a> <a href="#fnref:19" class="footnote-back-ref">↩</a></p></li> </ol>